Dr. Nischala Ammannagari
Claim this profileNew York Oncology Hematology, P.C.
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage III
Stage IV
Affiliated Hospitals
More about Nischala Ammannagari
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Nischala Ammannagari has experience with
- Placebo
- T-DM1
- Tucatinib
Breakdown of trials Nischala Ammannagari has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nischala Ammannagari specialize in?
Nischala Ammannagari focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage III.
Is Nischala Ammannagari currently recruiting for clinical trials?
No, Nischala Ammannagari is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Nischala Ammannagari has studied deeply?
Yes, Nischala Ammannagari has studied treatments such as Placebo, T-DM1, Tucatinib.
What is the best way to schedule an appointment with Nischala Ammannagari?
Apply for one of the trials that Nischala Ammannagari is conducting.
What is the office address of Nischala Ammannagari?
The office of Nischala Ammannagari is located at: New York Oncology Hematology, P.C., Albany, New York 12206 United States. This is the address for their practice at the New York Oncology Hematology, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.